Mutations in Penicillin-Binding Protein (PBP) Genes and in Non-PBP Genes during Selection of Penicillin-Resistant Streptococcus gordonii
- 1 December 2006
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 50 (12) , 4053-4061
- https://doi.org/10.1128/aac.00676-06
Abstract
Penicillin resistance in Streptococcus spp. involves multiple mutations in both penicillin-binding proteins (PBPs) and non-PBP genes. Here, we studied the development of penicillin resistance in the oral commensal Streptococcus gordonii . Cyclic exposure of bacteria to twofold-increasing penicillin concentrations selected for a progressive 250- to 500-fold MIC increase (from 0.008 to between 2 and 4 μg/ml). The major MIC increase (≥35-fold) was related to non-PBP mutations, whereas PBP mutations accounted only for a 4- to 8-fold additional increase. PBP mutations occurred in class B PBPs 2X and 2B, which carry a transpeptidase domain, but not in class A PBP 1A, 1B, or 2A, which carry an additional transglycosylase domain. Therefore, we tested whether inactivation of class A PBPs affected resistance development in spite of the absence of mutations. Deletion of PBP 1A or 2A profoundly slowed down resistance development but only moderately affected resistance in already highly resistant mutants (MIC = 2 to 4 μg/ml). Thus, class A PBPs might facilitate early development of resistance by stabilizing penicillin-altered peptidoglycan via transglycosylation, whereas they might be less indispensable in highly resistant mutants which have reestablished a penicillin-insensitive cell wall-building machinery. The contribution of PBP and non-PBP mutations alone could be individualized in DNA transformation. Both PBP and non-PBP mutations conferred some level of intrinsic resistance, but combining the mutations synergized them to ensure high-level resistance (≥2 μg/ml). The results underline the complexity of penicillin resistance development and suggest that inhibition of transglycosylase might be an as yet underestimated way to interfere with early resistance development.Keywords
This publication has 30 references indexed in Scilit:
- Mutational Analysis of Class A and Class B Penicillin-Binding Proteins in Streptococcus gordoniiAntimicrobial Agents and Chemotherapy, 2006
- Amino Acid Mutations Essential to Production of an Altered PBP 2X Conferring High-Level β-Lactam Resistance in a Clinical Isolate of Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2005
- Biochemical Characterization of Streptococcus pneumoniae Penicillin-Binding Protein 2b and Its Implication in β-Lactam ResistanceAntimicrobial Agents and Chemotherapy, 2004
- Antibiotics that inhibit cell wall biosynthesis induce expression of the Bacillus subtilisσW and σM regulonsMolecular Microbiology, 2002
- Endocarditis Caused by Penicillin‐Resistant Viridans Streptococci: 2 Cases and Controversies in TherapyClinical Infectious Diseases, 2001
- The crystal structure of the penicillin-binding protein 2x from Streptococcus pneumoniae and its acyl-enzyme form: implication in drug resistance 1 1Edited by R. HuberJournal of Molecular Biology, 2000
- X-ray structure of Streptococcus pneumoniae PBP2x, a primary penicillin target enzymeNature Structural & Molecular Biology, 1996
- A two‐component signal‐transducing system is involved in competence and penicillin susceptibility in laboratory mutants of Streptococcus pneumoniaeMolecular Microbiology, 1994
- Deletion analysis of the essentiality of penicillin-binding proteins 1A, 2B and 2X ofStreptococcus pneumoniaeFEMS Microbiology Letters, 1993
- Ecology of viridans streptococci in the oral cavity and pharynxOral Microbiology and Immunology, 1991